You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inoperable

Showing 1 - 25 of 1,253
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stereotactic Body Radiotherapy for Medically Inoperable

Recruiting
  • Kidney Neoplasm
  • +2 more
  • SBRT
  • Terrassa, Barcelona, Spain
    Consorci Sanitari de Terrassa
Apr 5, 2023

Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    Guoliang Shao
Aug 1, 2023

Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Immunonutrition Trial in Hefei (Whole-course Immunonutrition Combined

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • +3 more
  • Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs
  • Hefei, China
    Anhui provincial hospital
Apr 16, 2023

Pancreas Cancer Trial in Jinan (Sintilimab Plus mFFN and Radiation)

Recruiting
  • Pancreas Cancer
  • Sintilimab Plus mFFN and Radiation
  • Jinan, Shandong, China
    Department of Radiation Oncology, Shandong Cancer Hospital and I
Sep 21, 2023

Perihilar Cholangiocarcinoma Trial in Bucharest (Endoluminal radiofrequency ablation, Endoscopic biliary stenting)

Recruiting
  • Perihilar Cholangiocarcinoma
  • Endoluminal radiofrequency ablation
  • Endoscopic biliary stenting
  • Bucharest, Romania
    Gastroenterology Department, Colentina Hospital
Jan 26, 2023

Neurofibromatosis 1, Plexiform Neurofibroma, NF1 Trial (Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group

Not yet recruiting
  • Neurofibromatosis 1
  • +2 more
  • Test group (Group A): FCN-159 8 mg, orally, once daily;
  • Control group (Group B): Placebo, orally, once daily;
  • (no location specified)
Jun 16, 2023

Malignant Bowel Obstruction Trial in Buffalo (Dexamethasone, Metoclopramide, Octreotide)

Terminated
Has Results
  • Malignant Bowel Obstruction
  • Buffalo, New York
    Roswell Park Cancer Institute
Nov 9, 2022

Carcinoma, Pancreatic Ductal Trial in Trondheim (SonoVue, Chemotherapy)

Completed
  • Carcinoma, Pancreatic Ductal
  • Trondheim, Norway
    Department of Radiology, St Olavs Hospital
Jan 17, 2023

Cholecystitis, Acute Trial in Pamplona (Endoscopic treatment group (EUS-GBD group)

Recruiting
  • Cholecystitis, Acute
  • Endoscopic treatment group (EUS-GBD group
  • Pamplona, Navarra, Spain
    Hospital Universitario de Navarra
Jan 18, 2023

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Hepatocellular Carcinoma, Colorectal Cancer Trial in Hong Kong (Patient-Derived Tumor Organoids)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Colorectal Cancer
  • Patient-Derived Tumor Organoids
  • Hong Kong, N.t., Hong Kong
    Endoscopy Centre, Prince of Wales Hospital
Oct 12, 2023

Inoperable Disease, Bile Duct Cancer Trial in Cluj-Napoca (Endoscopic ultrasound with fine needle biopsy)

Recruiting
  • Inoperable Disease
  • Bile Duct Cancer
  • Endoscopic ultrasound with fine needle biopsy
  • Cluj-Napoca, Cluj, Romania
    IRGH "O. Fodor"
Jun 14, 2022

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Secondary Malignant Tumor of Liver Trial in Rozzano (Stereotactic Body Radiation Therapy, Microwave Ablation)

Terminated
  • Secondary Malignant Neoplasm of Liver
  • Stereotactic Body Radiation Therapy
  • Microwave Ablation
  • Rozzano, Milan, Italy
    Humanitas Research Hospital
Sep 14, 2022

Neurofibromatosis 1 (NF1), Plexiform Neurofibromas (PN) Trial run by the NCI (Selumetinib)

Active, not recruiting
  • Neurofibromatosis 1 (NF1)
  • Plexiform Neurofibromas (PN)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial (utidelone)

Not yet recruiting
  • Breast Neoplasms
  • Locally Advanced or Metastatic Breast Cancer
  • (no location specified)
May 30, 2022

Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)

Active, not recruiting
  • Neurofibromatosis 1
  • Neurofibroma Plexiform
  • Shanghai, China
  • +1 more
Jan 13, 2023

Pancreatic Cancer, Pancreatic Duct Stricture Trial in Helsinki (ERCP, Covered Self-expandable Metal Stent)

Recruiting
  • Pancreatic Cancer
  • Pancreatic Duct Stricture
  • ERCP
  • Covered Self-expandable Metal Stent
  • Helsinki, HUS, Finland
  • +1 more
Aug 15, 2022

Inoperable Hepatocellular Carcinoma Trial in Nanjing (TheraSphere™ Yttrium-90 Glass Microspheres, conventional Transarterial

Recruiting
  • Inoperable Hepatocellular Carcinoma
  • TheraSphere™ Yttrium-90 Glass Microspheres
  • conventional Transarterial Chemoembolization(cTACE)
  • Nanjing, Jiangsu, China
    Zhongda Hospital Southeast University
Jul 22, 2022

A Real-world Study of Inetetamab for First-line Treatment of MBC

Not yet recruiting
  • Breast Cancer
  • Real-world Study
  • (no location specified)
Aug 6, 2023

Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease Trial in New York (OBP-301,

Terminated
  • Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease
  • New York, New York
    Weill Cornell Medicine
Jul 6, 2022

Intrahepatic Cholangiocarcinoma Trial (derazantinib)

Available
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Jan 13, 2023

Risk Adaptive Scheme for SBRT for Thoracic Nodes Metastases

Active, not recruiting
  • Thoracic Nodes Metastases
  • Inoperable thoracic nodes metastases
  • Rozzano, Milano, Italy
    Davide Franceschini
May 3, 2022

High-Grade Glioma Trial in New York, Houston, Madison (CLR 131)

Not yet recruiting
  • High-Grade Glioma
  • CLR 131
  • New York, New York
  • +2 more
Nov 3, 2022

Organoids Trial in Hong Kong (PDO-guided treatment, standard of care)

Not yet recruiting
  • Organoids
  • PDO-guided treatment
  • standard of care
  • Hong Kong, N.t., Hong Kong
    Department of surgery , Prince of Wales Hospital
May 12, 2022